Intellectual Property India Publishes Patent Application for High Specific Activity/High Secretion Expression-Type Factor Viii Variant, Nucleic Acid Encoding High Expression-Type Factor Viii, And Use Thereof

MUMBAI, India, Sept. 22 -- Intellectual Property India has published a patent application (202647102509 A) filed by Jichi Medical University on August 25, 2026, for High Specific Activity/High Secretion Expression-Type Factor Viii Variant, Nucleic Acid Encoding High Expression-Type Factor Viii, And Use Thereof.

Inventors include Ohmori, Tsukasa; and Kashiwakura, Yuji.

The application for the patent was published on September 18, 2026, under issue no. 38/2026.

Abstract: The present invention provides: a human factor VIII variant characterized in that at least one amino acid residue selected from the group consisting of K213, S367, and F2196 of a wild-type human factor VIII is substituted with another amino acid, and characterized by havin...